{
  "_id": "0aa53c9c348fcb1dcad534d4ebd6495e6b82d7175e1730c93b9f9f476c0dfabe",
  "feed": "market-watch",
  "title": "Dow tumbles about 600 points as omicron fears ignite fresh selling to start Christmas week trade",
  "text": "<p>How are stock indexes trading?</p><p>The S&amp;P 500 SPX traded 66 points, or 1.4%, lower to 4,556.</p><p>The Dow Jones Industrial Average DJIA fell 583 points, or 1.7%, to 34,781.</p><p>The Nasdaq Composite Index COMP declined 237 points, or 1.6%, to reach 14,934.</p><p>On Friday, the Dow dropped more than 500 points, or 1.5%, with the S&amp;P 500 and Nasdaq Composite following it lower. For the week, the Dow lost 1.7%, the S&amp;P 500 dropped 1.9% and the Nasdaq tumbled 3%.</p><p>What's driving the markets?</p><p>Markets were slumping in the start to an abbreviated week of trading for most financial markets in observance of Christmas.</p><p>Worries about omicron, however, have sapped some of the joy out of the market for bullish investors, with lockdowns in parts of Europe weighing on sentiment.</p><p>News that President Joe Biden's signature $2 trillion spending plan appeared doomed also was being greeted with selling. Sen. Joe Manchin, D-W.Va., said on Sunday that he cannot support it — potentially handing Biden and Democrats a major political loss.</p><p>Prompted by the political wrangling, Goldman Sachs downgraded their U.S. growth forecasts for 2022, citing difficulties in getting the spending bill passed.</p><p>Last week's losses came as investors weighed the Federal Reserve's hawkish pivot, speeding up its reduction of monthly bond purchases and predicting three interest-rate hikes next year.</p><p>“With flight to safety being the overriding concern, lower bond yields are questioning the FOMC's ability to act as hawkish as they signaled last week. Markets are being challenged by a range of uncertainties at a time where thinner trading volumes ahead of the holiday period can exacerbate price swings,” said John Hardy, head of FX strategy at Saxo Bank, in a note to clients.</p><p>Need to know: These are the big levels to watch for the S&amp;P 500 and Nasdaq. Expect ‘wild trade,' if they break, warns this strategist.</p><p>Stock futures appeared to pare losses slightly after Moderna MRNA said its COVID-19 booster, when combined with two vaccines, offers 37-fold protection against the omicron variant.</p><p>That's as new COVID-19 cases are growing sharply in many parts of the world, fueled by the rapid spread of that variant. Dr. Anthony Fauci said Sunday that he expects record cases of COVID-19 this winter, and urged people to get vaccinated and get boosters. The Netherlands began a lockdown that will last until mid-January and the U.K. hasn't ruled out tighter pre-Christmas restrictions.</p><p>The World Economic Forum announced that its Davos meeting, which was due to be held in January, will be delayed to summer 2022, due to the spread of COVID-19. It's the second straight year that the conference has been postponed.</p><p>Read:Cathie Wood says stocks have corrected into ‘deep value territory' and won't let benchmarks ‘hold our strategies hostage'</p><p>Selling of perceived riskier assets extended to oil prices, which fell sharply on concerns of a growing hit to the global economy. Front-month West Texas intermediate crude CL. 1 fell 4.8% to $67.43 a barrel, while Brent crude BRN00, the global benchmark, lost 4.1% to $70.48 a barrel.</p><p>Which companies are in focus?</p><p>Oracle Corp.&#xa0;ORCL confirmed on Monday a deal to acquire electronic-medical-records company Cerner Corp.&#xa0;CERN&#xa0;for more than $30 billion in cash.&#xa0;</p><p>Shares of BP Midstream PartnersBPMP surged 13% in premarket trading after energy giant BP said it has entered into a definitive agreement to buy the master limited&#xa0;partnership in an all stock-deal.</p><p>Novavax shares NVAX rose 10% in premarket after the European Medicines Agency recommended granting Emergency Use Authorization for its COVID-19 vaccine.</p><p>ModernaMRNA stock rose 7% in premarket trading after the pharmaceutical group said a booster shot of its COVID-19 vaccine provided 37-fold protection against the omicron variant when combined with two vaccine shots.</p><p>BiogenBIIB shares gained over 2% after the biotechnology company said it would cut the price of its Alzheimer's drug aduhlem by 50% starting Jan. 1 to about $28,200 a year</p><p>Bluebird BioBLUE shares were halted in premarket trading after the company announced a partial clinical hold for patients under 18 in sickle cell gene therapy program</p><p>How are other assets trading?</p><p>The yield on the 10-year Treasury note BX:TMUBMUSD10Y fell about one basis point to 1.391%, according to Dow Jones Market Data. Treasury yields and prices move in opposite directions.</p><p>The ICE U.S. Dollar Index&#xa0;DXY,&#xa0;a measure of the currency against a half-dozen other monetary units, was down under 0.1%.</p><p>Gold futures&#xa0;GC00&#xa0;for February delivery&#xa0;GCG22 fell 0.4% to $1,797.60 an ounce.</p><p>The Stoxx Europe 600 Index&#xa0;XX:SXXP dropped 1.4%, while&#xa0;London's FTSE 100 index UK:UKX fell 1.1%.</p><p>In Asia, the Shanghai Composite Index&#xa0;CN:SHCOMP&#xa0;lost 1%, the Hang Seng Index&#xa0;HK:HSI fell 1.9% in Hong Kong, China's CSI 300&#xa0;XX:000300 skidded 1.5% lower and Japan's Nikkei 225 Index&#xa0;JP:NIK dropped 2.1%.</p>",
  "published": "2021-12-20T09:51:00.000Z",
  "tags": [
    {
      "id": "US38141G1040",
      "nexusId": "10038135",
      "name": "The Goldman Sachs Group, Inc.",
      "offsets": [
        {
          "start": 1047,
          "end": 1060
        },
        {
          "start": 1047,
          "end": 1054
        }
      ]
    }
  ]
}